1. Home
  2. ASPN vs ADPT Comparison

ASPN vs ADPT Comparison

Compare ASPN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • ADPT
  • Stock Information
  • Founded
  • ASPN 2001
  • ADPT 2009
  • Country
  • ASPN United States
  • ADPT United States
  • Employees
  • ASPN N/A
  • ADPT N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ASPN Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • ASPN Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • ASPN 1.1B
  • ADPT 929.8M
  • IPO Year
  • ASPN 2014
  • ADPT 2019
  • Fundamental
  • Price
  • ASPN $12.60
  • ADPT $5.94
  • Analyst Decision
  • ASPN Strong Buy
  • ADPT Buy
  • Analyst Count
  • ASPN 10
  • ADPT 4
  • Target Price
  • ASPN $30.80
  • ADPT $6.50
  • AVG Volume (30 Days)
  • ASPN 1.8M
  • ADPT 1.4M
  • Earning Date
  • ASPN 02-10-2025
  • ADPT 02-12-2025
  • Dividend Yield
  • ASPN N/A
  • ADPT N/A
  • EPS Growth
  • ASPN N/A
  • ADPT N/A
  • EPS
  • ASPN 0.02
  • ADPT N/A
  • Revenue
  • ASPN $413,830,000.00
  • ADPT $177,282,000.00
  • Revenue This Year
  • ASPN $92.34
  • ADPT $6.48
  • Revenue Next Year
  • ASPN $10.74
  • ADPT $18.84
  • P/E Ratio
  • ASPN $649.19
  • ADPT N/A
  • Revenue Growth
  • ASPN 93.28
  • ADPT N/A
  • 52 Week Low
  • ASPN $10.75
  • ADPT $2.28
  • 52 Week High
  • ASPN $33.15
  • ADPT $7.07
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 39.46
  • ADPT 61.49
  • Support Level
  • ASPN $12.68
  • ADPT $5.98
  • Resistance Level
  • ASPN $14.53
  • ADPT $6.93
  • Average True Range (ATR)
  • ASPN 0.68
  • ADPT 0.45
  • MACD
  • ASPN 0.15
  • ADPT 0.03
  • Stochastic Oscillator
  • ASPN 28.75
  • ADPT 75.53

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: